Gaoma Therapeutics
Les Auvergnes
About Gaoma Therapeutics
Gaoma Therapeutics is a biotechnology company that develops therapeutic molecules for neurological and inflammatory diseases. The company’s initial medicine candidate, GAO-3-02, is a novel proprietary active component. Gaoma Therapeutics specializes in epilepsy and cognitive diseases, but it plans to investigate the potential of its compounds in other areas as well.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.3M
- Funding stage: Seed
- Last round: Seed (Apr 2021)
- Website: gaoma-tx.com
Industries & Categories
Biotechnology, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/gaoma-therapeutics-51057 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.